Evidence map›Paper›PMID 41678734›Full record

ArticleBriefings in bioinformatics2026

Dynamic-GLEP: a dynamics-informed deep learning framework for ligand efficacy prediction in representative Class A GPCRs.

Zhiyi Chen, Yongxin Hao, Yuhong Su, Hans Ågren, Mingan Chen, Zhehuan Fan, Duanhua Cao, Jiacheng Xiong, Wei Zhang, Jin Liu and 5 more

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Zhiyi Chen *School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing 210023, China.
Yongxin Hao *Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China.
Yuhong SuLingang Laboratory, 2380 Hechuan Road, Shanghai 200031, China.
Hans ÅgrenDivision of X-ray Photon Science, Department of Physics and Astronomy, Uppsala University, Box 516, SE-751 20, Uppsala, Sweden.
Mingan ChenDrug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China.
Zhehuan FanDrug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China.
Duanhua CaoDrug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China.ORCID 0009-0006-0140-7998
Jiacheng XiongDrug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China.
Wei ZhangDrug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China.
Jin LiuDrug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China.
Xutong LiDrug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China.ORCID 0000-0001-9547-0643
Mingyue ZhengSchool of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing 210023, China.ORCID 0000-0002-3323-3092
Xi ChengDrug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China.
Dingyan WangLingang Laboratory, 2380 Hechuan Road, Shanghai 200031, China.ORCID 0000-0003-2964-7425
Dan TengDrug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China.ORCID 0000-0002-1253-3408

Funding

China Postdoctoral Science Foundation 2024 M763419Fund of Youth Innovation Promotion Association 2022077National Academic Infrastructure for Supercomputing in Sweden (NAISS) for offering computational resources at Alvis NAISS 2023/3-40National Key Research and Development Program of China 2021YFA1301900National Key Research and Development Program of China 2022YFC3400504National Key Research and Development Program of China 2023YFC2305904National Natural Science Foundation of China 82273855National Natural Science Foundation of China 82404513National Natural Science Foundation of China T2225002Postdoctoral Fellowship Program of CPSF GZC20232846Shanghai Municipal Science and Technology Major Project, Strategic Priority Research Program of the Chinese Academy of Sciences XDB0850000Shanghai Sailing Program 22YF1460800SIMM-SHUTCM Traditional Chinese Medicine Innovation Joint Research Program E2G805H
6 · The paper itself

Abstract

G protein-coupled receptors (GPCRs) represent the largest membrane protein family and remain central targets in drug discovery. Ligand efficacy reflects the ability to modulate receptor conformational states and extends beyond binding affinity to underpin functional selectivity. However, most computational approaches still emphasize affinity prediction, with limited capacity to capture the conformational dynamics driving efficacy. Here, we introduce Dynamic-GLEP, a structure- and mechanism-aware framework that integrates molecular dynamics (MD)-derived conformational ensembles with transfer learning on equivariant graph neural networks. By constructing multi-conformation receptor-ligand complexes and fine-tuning the EquiScore model, Dynamic-GLEP identifies conformation-dependent interaction features to distinguish agonists from nonagonists. Applied to the 5-HT1A receptor, the framework achieved an area under the curve (AUC) of 0.74 in cross-validation and 0.71 on an external Food and Drug Administration (FDA)-related dataset. Comparative analyses showed that Holo-based models are advantageous for scaffold optimization, whereas Apo-derived ensembles provided greater adaptability to chemically diverse ligands. Furthermore, extension to the adenosine A2A receptor yielded high performance (AUC > 0.85), underscoring the method's robustness and transferability under data-scarce conditions. Collectively, these results highlight Dynamic-GLEP as a reliable and interpretable platform for ligand efficacy prediction in Class A GPCRs, with broad potential to support virtual screening, candidate prioritization, and mechanism-driven drug design.

Indexed as

Deep LearningMolecular Dynamics SimulationReceptors, G-Protein-CoupledDrug DiscoveryGraph Neural NetworksHumansLigandsProtein ConformationReceptor, Serotonin, 5-HT1ALigandsReceptor, Serotonin, 5-HT1AReceptors, G-Protein-Coupledconformational ensemblesdeep learningGPCR ligand efficacymolecular dynamicsstructure-based drug designtransfer learning

Identifiers

PMID41678734
PMCPMC12900074

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.